AFT Pharmaceuticals Limited AFP.AX Stock
AFT Pharmaceuticals Limited Price Chart
AFT Pharmaceuticals Limited AFP.AX Financial and Trading Overview
| AFT Pharmaceuticals Limited stock price | 2.85 AUD |
| Previous Close | 3.4 AUD |
| Open | 3.4 AUD |
| Bid | 3.3 AUD x N/A |
| Ask | 3.41 AUD x N/A |
| Day's Range | 3.4 - 3.4 AUD |
| 52 Week Range | 2.9 - 3.7 AUD |
| Volume | 162 AUD |
| Avg. Volume | 848 AUD |
| Market Cap | 356.54M AUD |
| Beta (5Y Monthly) | 0.244061 |
| PE Ratio (TTM) | 37.77778 |
| EPS (TTM) | 0.09 AUD |
| Forward Dividend & Yield | 0.01 (0.20%) |
| Ex-Dividend Date | June 16, 2023 |
| 1y Target Est | N/A |
AFP.AX Valuation Measures
| Enterprise Value | 389.85M AUD |
| Trailing P/E | 37.77778 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.2761884 |
| Price/Book (mrq) | 4.864092 |
| Enterprise Value/Revenue | 2.489 |
| Enterprise Value/EBITDA | 19.611 |
Trading Information
AFT Pharmaceuticals Limited Stock Price History
| Beta (5Y Monthly) | 0.244061 |
| 52-Week Change | -2.29% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.7 AUD |
| 52 Week Low | 2.9 AUD |
| 50-Day Moving Average | 3.32 AUD |
| 200-Day Moving Average | 3.28 AUD |
AFP.AX Share Statistics
| Avg. Volume (3 month) | 848 AUD |
| Avg. Daily Volume (10-Days) | 674 AUD |
| Shares Outstanding | 104.87M |
| Float | 28.18M |
| Short Ratio | N/A |
| % Held by Insiders | 73.81% |
| % Held by Institutions | 5.61% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.011 |
| Trailing Annual Dividend Yield | 0.32% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 6.80% |
| Operating Margin (ttm) | 12.55% |
| Gross Margin | 46.59% |
| EBITDA Margin | 12.69% |
Management Effectiveness
| Return on Assets (ttm) | 8.92% |
| Return on Equity (ttm) | 15.71% |
Income Statement
| Revenue (ttm) | 156.64M AUD |
| Revenue Per Share (ttm) | 1.49 AUD |
| Quarterly Revenue Growth (yoy) | 21.50% |
| Gross Profit (ttm) | 72.98M AUD |
| EBITDA | 19.88M AUD |
| Net Income Avi to Common (ttm) | 10.65M AUD |
| Diluted EPS (ttm) | 0.09 |
| Quarterly Earnings Growth (yoy) | -41.00000000000000000000000000000000% |
Balance Sheet
| Total Cash (mrq) | 4.75M AUD |
| Total Cash Per Share (mrq) | 0.05 AUD |
| Total Debt (mrq) | 38.05M AUD |
| Total Debt/Equity (mrq) | 51.93 AUD |
| Current Ratio (mrq) | 2.378 |
| Book Value Per Share (mrq) | 0.699 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 11.63M AUD |
| Levered Free Cash Flow (ttm) | -4966500 AUD |
Profile of AFT Pharmaceuticals Limited
| Country | Australia |
| State | N/A |
| City | Auckland |
| Address | 129 Hurstmere Road |
| ZIP | 0622 |
| Phone | 64 9 488 0232 |
| Website | https://www.aftpharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 100 |
AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.
Q&A For AFT Pharmaceuticals Limited Stock
What is a current AFP.AX stock price?
AFT Pharmaceuticals Limited AFP.AX stock price today per share is 2.85 AUD.
How to purchase AFT Pharmaceuticals Limited stock?
You can buy AFP.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AFT Pharmaceuticals Limited?
The stock symbol or ticker of AFT Pharmaceuticals Limited is AFP.AX.
Which industry does the AFT Pharmaceuticals Limited company belong to?
The AFT Pharmaceuticals Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does AFT Pharmaceuticals Limited have in circulation?
The max supply of AFT Pharmaceuticals Limited shares is 109.44M.
What is AFT Pharmaceuticals Limited Price to Earnings Ratio (PE Ratio)?
AFT Pharmaceuticals Limited PE Ratio is 31.66666400 now.
What was AFT Pharmaceuticals Limited earnings per share over the trailing 12 months (TTM)?
AFT Pharmaceuticals Limited EPS is 0.09 AUD over the trailing 12 months.
Which sector does the AFT Pharmaceuticals Limited company belong to?
The AFT Pharmaceuticals Limited sector is Healthcare.